These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 22814721)

  • 21. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
    Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
    Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
    Li TY; Yang Y; Zhou G; Tu ZK
    World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current concepts on immunopathogenesis of hepatitis B virus infection.
    Peeridogaheh H; Meshkat Z; Habibzadeh S; Arzanlou M; Shahi JM; Rostami S; Gerayli S; Teimourpour R
    Virus Res; 2018 Feb; 245():29-43. PubMed ID: 29273341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
    Zhang Z; Zhang JY; Wang LF; Wang FS
    J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate and adaptive immune responses in hepatitis B virus infection.
    Das A; Maini MK
    Dig Dis; 2010; 28(1):126-32. PubMed ID: 20460900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathogenesis of HBV Infection.
    Wu J; Han M; Li J; Yang X; Yang D
    Adv Exp Med Biol; 2020; 1179():71-107. PubMed ID: 31741334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immunity and HBV persistence.
    Chiale C; Marchese AM; Robek MD
    Curr Opin Virol; 2021 Aug; 49():13-20. PubMed ID: 33992859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota in the innate immunity against hepatitis B virus - implication in age-dependent HBV clearance.
    Wu LL; Huang TS; Shyu YC; Wang CL; Wang HY; Chen PJ
    Curr Opin Virol; 2021 Aug; 49():194-202. PubMed ID: 34242953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
    Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
    J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection.
    Golsaz-Shirazi F; Amiri MM; Shokri F
    Rev Med Virol; 2018 Nov; 28(6):e2007. PubMed ID: 30175481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral clearance without destruction of infected cells during acute HBV infection.
    Guidotti LG; Rochford R; Chung J; Shapiro M; Purcell R; Chisari FV
    Science; 1999 Apr; 284(5415):825-9. PubMed ID: 10221919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B infection: current concepts and future challenges.
    Nebbia G; Peppa D; Maini MK
    QJM; 2012 Feb; 105(2):109-13. PubMed ID: 22252919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population.
    Shoraka S; Mohebbi SR; Hosseini SM; Hosseini Razavi A; Hatami Y; Sharifian A; Rostami-Nejad M; Asadzadeh Aghdaei H; Zali MR
    Microb Pathog; 2019 Mar; 128():263-267. PubMed ID: 30639626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immune responses in hepatitis B virus (HBV) infection.
    Busca A; Kumar A
    Virol J; 2014 Feb; 11():22. PubMed ID: 24507433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.